Alnylam Pharmaceuticals, Inc. (ALNY) financial statements (2020 and earlier)

Company profile

Business Address 675 WEST KENDALL STREET
CAMBRIDGE, MA 02142
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,7211,0841,6916271,081697246
Cash and cash equivalents9234206451941817553
Short-term investments7986641,045433900622193
Restricted cash and investments00     
Receivables481934238404
Inventory, net of allowances, customer advances and progress billings5524    
Inventory5524     
Other undisclosed current assets7473402217104
Total current assets:1,8971,2011,7656721,105746254
Noncurrent Assets
Operating lease, right-of-use asset223
Property, plant and equipment396321182115282216
Long-term investments and receivables  14325252280150
Long-term investments  14325252280150
Restricted cash and investments154530150   
Other noncurrent assets109421  
Other undisclosed noncurrent assets     32 
Total noncurrent assets:644374230591281333167
TOTAL ASSETS:2,5421,5751,9951,2631,3871,080421
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21717210197464620
Accounts payable3960285417156
Accrued liabilities1781137242292414
Employee-related liabilities     7 
Deferred revenue107
Debt28      
Deferred rent credit 4
Deferred revenue and credits4435172534
Deferred tax liabilities    32 
Contract with customer, liability3
Other undisclosed current liabilities     (7) 
Total current liabilities:353179144132629554
Noncurrent Liabilities
Long-term debt and lease obligation2763030150   
Long-term debt, excluding current maturities 3030150   
Operating lease, liability276
Liabilities, other than long-term debt305635461604896
Deferred revenue and credits5058584896
Deferred revenue296
Contract with customer, liability0
Deferred rent credit 58
Other liabilities95431  
Total noncurrent liabilities:5829384211604896
Total liabilities:935273228343122143150
Stockholders' equity
Stockholders' equity attributable to parent1,6071,3021,7669201,265936270
Common stock1111111
Additional paid in capital5,0914,1753,9482,6102,5061,843846
Accumulated other comprehensive income (loss)(34)(33)(34)(33)44920
Accumulated deficit(3,451)(2,841)(2,148)(1,657)(1,247)(957)(596)
Total stockholders' equity:1,6071,3021,7669201,265936270
TOTAL LIABILITIES AND EQUITY:2,5421,5751,9951,2631,3871,080421

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues169759047415147
Revenue, net9047415147
Cost of revenue(15)(22)     
Cost of goods and services sold(15)(2)     
Gross profit:155539047415147
Operating expenses(1,016)(867)(590)(472)(337)(456)(140)
Operating loss:(862)(815)(500)(425)(296)(405)(93)
Nonoperating income4254914641
Investment income, nonoperating3729128651
Other nonoperating income (expense)(4)4(3)602(0)
Loss from continuing operations before income taxes:(820)(761)(491)(410)(290)(401)(92)
Income tax expense (benefit)(2)(1)   403
Net loss available to common stockholders, diluted:(821)(761)(491)(410)(290)(360)(89)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(821)(761)(491)(410)(290)(360)(89)
Other comprehensive income (loss)(1)1(1)    
Other undisclosed comprehensive income1      
Comprehensive loss:(821)(760)(492)(410)(290)(360)(89)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)  (38)(44)294
Comprehensive loss, net of tax, attributable to parent:(822)(760)(492)(448)(334)(331)(85)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: